GEN Pharm SA
GEN Pharm reported total assets of 11,656 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of GEN Pharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -57 % Total assets -51 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GEN Pharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
GEN Pharm's financial analysis
- Solvency80.5%sector median: 57.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GEN Pharm
GEN Pharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0897.952.853
- VAT number
- BE0897952853
- Peppol
- Registered · 0208:0897952853 · as of 11 Nov 2026
- Legal form
- SA
- Incorporated
- 16 May 2008
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Other legal activities (NACE 69109)
GEN Pharm (SA) has been based in Brussels since 2008, active in: other legal activities. For 2025, it reports a net loss of 5,339 € and equity of 9,381 €; its revenue is not published. Its solvency stands at 80.5%, above the median of its sector (57.5%).
Companies similar to GEN Pharm
Companies in the same business, of comparable size and area, outside its group.
- Artikel vijf Legal activities Mechelen · balance sheet 4,827 €
- QVDS Consult Legal activities Grimbergen · balance sheet 102,784 €
- BB Management Legal activities Meise · balance sheet 154,854 €
- O.T.C. Other business support service activities n.e.c. Waterloo · balance sheet 11,177 €
- SJU Legal activities Tessenderlo-Ham · balance sheet 19,193 €
- Th.Inc Legal activities Laarne · balance sheet 10,575 €
- Erfrechtadviseur Legal activities Tessenderlo-Ham · balance sheet 14,025 €
- Asthi Legal activities Hove · balance sheet 18,627 €
Frequently asked questions about GEN Pharm
What is the revenue of GEN Pharm?
GEN Pharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GEN Pharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0897952853 for GEN Pharm, if the company is VAT-registered. Its company number (CBE) is 0897.952.853.
Where is the registered office of GEN Pharm?
According to the CBE register, the registered office of GEN Pharm is in 1000 Brussels.
What is the equity of GEN Pharm?
At the close of the 2025 financial year, the equity of GEN Pharm amounts to 9,381 €, a solvency of 80.5% of total assets.
Who manages GEN Pharm?
The register lists 3 active mandates at GEN Pharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of GEN Pharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →